Hexo (TSX:HEXO) Stock Soars 9% as Revenue Nearly Doubled in Q2

Hexo (TSX:HEXO)(NYSE:HEXO) stock soared by 9% shortly after the opening bell, as investors cheered a strong rise in revenue in the second quarter.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Hexo (TSX:HEXO)(NYSE:HEXO) released its second-quarter financial results on Thursday morning. Hexo stock soared by 9% shortly after the opening bell, as investors cheered a strong rise in revenue.

The pot company strengthened its positions in several key Canadian markets outside Quebec while maintaining its leading competitive position in Quebec.

Hexo posted a loss of $20.8 million in the second quarter

Hexo is a consumer packaged goods cannabis company, which creates and distributes products to serve the global cannabis market. It serves the Canadian adult-use markets under its HEXO Cannabis, Up Cannabis, and Original Stash brands, and it serves the medical market under HEXO medical cannabis.

Hexo posted a loss of $20.8 million in its most recent quarter, as revenue nearly doubled from a year earlier.

The cannabis company said its loss stood at $0.17 per diluted share for the quarter ended January 31.

The result compares to a loss of $298.2 million, or $4.52 per diluted share a year earlier, when the company incurred significant one-time charges related to its goodwill and intangible assets.

Hexo’s total net revenue were $32.8 million, up 94% from the same quarter a year earlier and 12% up from the first quarter of fiscal 2021 ended October 31, 2021. The company achieved positive adjusted EBITDA. This quarter marks Hexo’s seventh consecutive quarter of adjusted EBITDA improvement.

Non-beverage Canadian adult-use revenue increased by 72% from the second quarter of 2020.

Adult-use net revenue rose 10.5% in the second quarter, marking the fifth consecutive quarter of growth.

Hexo remains number one in Quebec

Hexo has kept its number one position for market share in Quebec while increasing adult-use net revenue in the rest of Canada to 49% of the company’s sales mix, up from 44% in the first quarter of 2021.

Sebastien St-Louis, Hexo CEO and co-founder, said in a statement: “Our continued focus on delighting consumers has seen us increase our market share across Canada while maintaining the number one position in Quebec. We’re also very excited to have launched ‘powered by HEXO’ CBD beverages in Colorado. Our net revenues and gross margin have continued to improve year over year, bolstered by our premium product mix with the relaunch of UP Cannabis.”

UP Cannabis brand gross revenues increased to $3.2 million, representing 8% of total adult-use, non-beverage gross revenue in the second quarter of 2021 compared to less than 1% in the first quarter due to the successful relaunch of the UP brand at the end of first quarter.

Brand mix, including the UP Cannabis brand, increased non-beverage adult-use gross margin  to 37%, up from 36% in the first quarter.

Hexo has maintained the number one position in the beverages category with net revenues up 11% from the first quarter.

Last month, Hexo announced a deal to buy competitor Zenabis Global in a $235 million deal that will give the cannabis company a European footprint and strengthen its domestic business.

Sébastien St-Louis said the deal with Zenabis will help accelerate national and international growth. The acquisition would place Hexo firmly in the top three positions among licensed producers for sales of adult cannabis in Canada, according to the most recent interim quarterly financial statements.

Hexo stock is overvalued

While Hexo’s growth is impressive, it’s preferable to wait before buying shares, because Hexo stock is overvalued, with a P/S of 12.34.

Should you invest $1,000 in Hexo Corp right now?

Before you buy stock in Hexo Corp, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Hexo Corp wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,058.57!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 38 percentage points since 2013*.

See the Top Stocks * Returns as of 2/20/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Stephanie Bedard-Chateauneuf has no position in any of the stocks mentioned. The Motley Fool recommends HEXO.

If You Thought Apple and Microsoft Were Big, You Need to Read This.

The steel industry produced the world's first $1 billion company in 1901, and it wasn't until 117 years later that technology giant Apple became the first-ever company to reach a $1 trillion valuation.

But what if I told you artificial intelligence (AI) is about to accelerate the pace of value creation? AI has the potential to produce several trillion-dollar companies in the future, and The Motley Fool is watching one very closely right now.

Don't fumble this potential wealth-building opportunity by navigating it alone. The Motley Fool has a proven track record of picking revolutionary growth stocks early, from Netflix to Amazon, so become a premium member today.

See the 'AI Supercycle' Stock

More on Cannabis Stocks

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Should You Buy Canopy Growth Stock or Green Thumb Stock Today?

Let's dive into two cannabis giants, and which one may be the better pick for long-term investors.

Read more »